PubMed

A study comparing two protocols of treatment with intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

Arias L, Caminal JM, Casas L, Masuet C, Badia MB, Rubio M, Pujol O, Arruga J.

Br J Ophthalmol. 2008 Dec;92(12):1636-41. Epub 2008 Sep 9.PMID: 18782803 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

Retina. 2007 Apr-May;27(4):432-8.PMID: 17420694 [PubMed - indexed for MEDLINE]Related articles

Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.

Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA; Pan-American Collaborative Retina Study Group.

Retina. 2008 Nov-Dec;28(10):1387-94.PMID: 18827735 [PubMed - indexed for MEDLINE]Related articles

Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration.

Lazic R, Gabric N.

Graefes Arch Clin Exp Ophthalmol. 2007 Jan;245(1):68-73. Epub 2006 Nov 18.PMID: 17111146 [PubMed - indexed for MEDLINE]Related articles

A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations.

Algvere PV, Steén B, Seregard S, Kvanta A.

Acta Ophthalmol. 2008 Aug;86(5):482-9. Epub 2007 Dec 14.PMID: 18162062 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

Spaide RF, Laud K, Fine HF, Klancnik JM Jr, Meyerle CB, Yannuzzi LA, Sorenson J, Slakter J, Fisher YL, Cooney MJ.

Retina. 2006 Apr;26(4):383-90.PMID: 16603955 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study.

Bashshur ZF, Haddad ZA, Schakal A, Jaafar RF, Saab M, Noureddin BN.

Am J Ophthalmol. 2008 Feb;145(2):249-256. Epub 2007 Dec 11.PMID: 18067876 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.

Furino C, Boscia F, Recchimurzo N, Besozzi G, Cardascia N, Sborgia L, Niro A, Sborgia C.

Acta Ophthalmol. 2009 Jun;87(4):404-7. Epub 2008 Sep 8.PMID: 18782335 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to age-related macular degeneration in an Indian population.

Azad RV, Khan MA, Chanana B, Azad S.

Jpn J Ophthalmol. 2008 Jan-Feb;52(1):52-6. Epub 2008 Mar 28.PMID: 18369701 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration.

Aisenbrey S, Ziemssen F, Völker M, Gelisken F, Szurman P, Jaissle G, Grisanti S, Bartz-Schmidt KU.

Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):941-8. Epub 2006 Dec 21.PMID: 17186262 [PubMed - indexed for MEDLINE]Related articles

Treatment of choroidal neovascularization using intravitreal bevacizumab.

Pedersen R, Soliman W, Lund-Andersen H, Larsen M.

Acta Ophthalmol Scand. 2007 Aug;85(5):526-33. Epub 2007 May 18.PMID: 17511757 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.

Emerson MV, Lauer AK, Flaxel CJ, Wilson DJ, Francis PJ, Stout JT, Emerson GG, Schlesinger TK, Nolte SK, Klein ML.

Retina. 2007 Apr-May;27(4):439-44.PMID: 17420695 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.

Weigert G, Michels S, Sacu S, Varga A, Prager F, Geitzenauer W, Schmidt-Erfurth U.

Br J Ophthalmol. 2008 Mar;92(3):356-60.PMID: 18303156 [PubMed - indexed for MEDLINE]Related articles

Effects of ranibizumab in patients with subfoveal choroidal neovascularization attributable to age-related macular degeneration.

Rothenbuehler SP, Waeber D, Brinkmann CK, Wolf S, Wolf-Schnurrbusch UE.

Am J Ophthalmol. 2009 May;147(5):831-7. Epub 2009 Feb 13.PMID: 19217019 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration: a short-term study.

Chen CY, Wong TY, Heriot WJ.

Am J Ophthalmol. 2007 Mar;143(3):510-2. Epub 2006 Nov 13.PMID: 17317398 [PubMed - indexed for MEDLINE]Related articles

Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.

Smith BT, Dhalla MS, Shah GK, Blinder KJ, Ryan EH Jr, Mittra RA.

Retina. 2008 May;28(5):675-81.PMID: 18463509 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.

Ladas ID, Kotsolis AI, Papakostas TD, Rouvas AA, Karagiannis DA, Vergados I.

Retina. 2007 Sep;27(7):891-6.PMID: 17891013 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ.

Ophthalmology. 2006 Mar;113(3):363-372.e5. Epub 2006 Feb 3.PMID: 16458968 [PubMed - indexed for MEDLINE]Related articles

Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.

Lazic R, Gabric N.

Ophthalmology. 2007 Jun;114(6):1179-85.PMID: 17544776 [PubMed - indexed for MEDLINE]Related articles

Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration.

Joeres S, Kaplowitz K, Brubaker JW, Updike PG, Collins AT, Walsh AC, Romano PW, Sadda SR.

Ophthalmology. 2008 Feb;115(2):347-354.e2. Epub 2007 Jul 12.PMID: 17628685 [PubMed - indexed for MEDLINE]Related articles